Loading...
SAT-516 A Severe Case of Pembrolizumab-Induced Thyroiditis
Pembrolizumab, a programmed death 1 (PD-1) inhibitor used for advanced malignancies, can be associated with thyroid dysfunction.(1-2) Specifically, thyroiditis occurs in nearly 2.3% of individuals.(2) The hyperthyroid phase is typically non-severe, requiring only beta blockers. Our case illustrates...
Na minha lista:
| Udgivet i: | J Endocr Soc |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208842/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1895 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|